1)- Gabriel Vizgan, Michael Huamán, Kevin Rychik, Max Edeson, Jerry G Blaivas. Ketamine-induced uropathy: A narrative systemic review of surgical outcomes of reconstructive surgery.BJUI compass. 2023, 4 (4): 377-384
2)- Zach Dovey, Amir Horowitz, Nikhil Waingankar. The influence of lifestyle changes (diet, exercise and stress reduction) on prostate cancer tumour biology and patient outcomes: A systematic review.BJUI compass. 2023, 4 (4): 385-416
3)- Yukiko Kouchi, Akihiko Ozaki, Yudai Kaneda, Divya Bhandari, Kazuma Saito, Hiroaki Shimmura. An examination of the relationship between satisfaction with overactive bladder (OAB) treatment and the doctor-patient gender: A questionnaire-based single-institution study.BJUI compass. 2023, 4 (4): 417-419
4)- Juan Morote, Ángel Borque-Fernando, Marina Triquell, José M Abascal, Pol Servian, Jacques Planas, Olga Mendez, Luis M Esteban, Enrique Tilla. A risk-organised model for clinically significant prostate cancer early detection.BJUI compass. 2023, 4 (4): 420-422
5)- Stephen Kiboneka, Aggrey Anok, Regina Nakabuye, Silas Odiya, Julius Magembe, Rose Nazziwa, Charles Ddamulira, Andrew Mulooki, Ronald Moses Galiwango, Stephen Watya, Philip S Li, Richard K Lee, Ronald H Gray, Godfrey Kigozi, Edward Nelson Kankaka. Timing for maximum anaesthetic effect of topical cream during early infant circumcision (EIC) in Rakai, Uganda.BJUI compass. 2023, 4 (4): 423-429
6)- Laura Kelly, Judith Shore, James Wright, Craig Patrick, Hayden Holmes. Economic evaluation of Optilume, a drug-coated balloon for recurrent anterior male urethral stricture.BJUI compass. 2023, 4 (4): 430-436
7)- Mohamed S Al-Marhoon, Ahmed Al-Harrasi, Khurram Siddiqui, Mohammed Ashique, Haytham Ali, Badreldin H Ali. Effects of frankincense on experimentally induced renal stones in rats.BJUI compass. 2023, 4 (4): 437-445
8)- Nicholas Bullock, Mohamed Mubarak, Ceri Morris, Colette Clements, Clare Geere, Sarah Tidball, Elizabeth Bois, Michael Davies, Jonathan Featherstone, Krishna Narahari, Ian Weeks, Howard Kynaston. Perception of urinary biomarker tests among patients referred with suspected urological malignancy.BJUI compass. 2023, 4 (4): 446-454
9)- H Yildirim, M S Schuurman, C V Widdershoven, B W Lagerveld, L van den Brink, A E C Ruiter, H P Beerlage, R J A van Moorselaar, N M Graafland, A Bex, K K H Aben, P J Zondervan. Variation in the management of cT1 renal cancer by surgical hospital volume: A nationwide study.BJUI compass. 2023, 4 (4): 455-463
10)- Anjali Zarkar, Dan Henderson, Antony Carver, Geoff Heyes, Victoria Harrop, Sarah Tutill, Julie Kilkenny, Andrea Marshall, Nada Elbeltagi, Helen Howard. First UK patient cohort treated with stereotactic ablative radiotherapy for primary kidney cancer.BJUI compass. 2023, 4 (4): 464-472
11)- Andrés Camacho, Fatima Salah, Camden P Bay, Jonathan Waring, Renato Umeton, Michelle S Hirsch, Alexander P Cole, Adam S Kibel, Massimo Loda, Clare M Tempany, Fiona M Fennessy. PI-RADS 3 score: A retrospective experience of clinically significant prostate cancer detection.BJUI compass. 2023, 4 (4): 473-481
12)- Nikhil Vasdev, Philip Charlesworth, Mark Slack, Jim Adshead. Preclinical evaluation of the Versius surgical system: A next-generation surgical robot for use in minimal access prostate surgery.BJUI compass. 2023, 4 (4): 482-490